Product Restrictions

All systems are functioning normally.

Last Updated 06:41:45 GMT

Restrictions on Transactions in Various Barclays ETN Options on Cboe Options Exchange

April 13, 2018

Effective after the close of trading on April 12, 2018, Barclays Bank PLC delisted certain existing commodity ETNs from the NYSE Arca exchange. Please click on the title for complete details.

Restrictions on Transactions in NTT DOCOMO, Inc (DCM) on Cboe Options Exchange

April 12, 2018

Effective April 12, 2018, NTT Docomo, Inc (DCM) was delisted from the NYSE and moved its listing to the Other-OTC Market under the symbol DCMYY. Please click on the title for complete details.

Restrictions on Transactions in Celadon Group, Inc. (CGIP) on Cboe Exchange

April 04, 2018

Effective April 4, 2018, Celadon Group, Inc. (CGIP) was delisted from the NYSE. Therefore, trading in CGIP options will be subject to restrictions. Please click on the title for complete details.

Restrictions on Transactions in Orexigen Therapeutics Inc. (OREXQ) on Cboe and C2 Exchanges

April 04, 2018

Effective April 4, 2018, Orexigen Therapeutics Inc. (OREXQ) was delisted from the NASD. Therefore, trading in OREXQ options will be subject to restrictions. Please click on the title for complete details.

Restrictions on Transactions in Willbros Group, Inc (WG) on Cboe, C2, BZX and EDGX Options Exchanges

March 27, 2018

Effective March 27, 2018, Willbros Group, (WG) was delisted from the NYSE. Therefore, trading in WG options will be subject to restrictions. Please click on the title for complete details.

Restrictions on Transactions in CCUR Holdings, Inc (CCUR) on Cboe, C2, BZX and EDGX Options Exchanges

March 27, 2018

Effective March 27, 2018, CCUR Holdings, (CCUR) was delisted from the NASDAQ. Therefore, trading in CCUR options will be subject to restrictions. Please click on the title for complete details.